Circulating GDF‐15 levels correlated significantly with other established cardiovascular biomarkers and inflammatory status in treatment‐naïve cancer patients in line with the proposed presence of a subclinical myocardial involvement with worsening disease severity. This evidence concerns the gene GDF15 and cancer.